J Curve in Hypertension

被引：10

作者：

Dudenbostel T. ^{[1
,2
]}

Oparil S. ^{[1
]}

机构：

[1] Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL

[2] not available, Birmingham, AL, 35294-2041, 933 19th Street S, Community Health Services Bldg. (CHSB)

来源：

Current Cardiovascular Risk Reports | 2012年 / 6卷 / 4期

关键词：

Chronic kidney disease; Comorbidities; Coronary artery disease; Diastolic; Elderly; Morbidity; Mortality; Systolic;

D O I：

10.1007/s12170-012-0246-0

中图分类号：

学科分类号：

摘要：

The relationship between blood pressure and cardiovascular disease risk among treated hypertensives is J-shaped: risk is increased at high levels of blood pressure, falls in parallel with blood pressure reduction and increases again when blood pressure falls below a nadir (the point at which blood pressure is too low to maintain perfusion of vital organs). Randomized controlled trials of antihypertensive treatment have identified J-shaped relationships between achieved systolic and diastolic blood pressures and all-cause mortality, as well as fatal and nonfatal cardiovascular events, but not stroke or renal outcomes, in the general population of hypertensives and high-risk prehypertensives, particularly in subgroups such as the elderly and those with coronary artery disease, chronic kidney disease, diabetes, left ventricular hypertrophy, and high cardiovascular risk because of multiple comorbidities and concomitant risk factors. Blood pressure targets <130-140/70-85 mm Hg were not beneficial for any outcome except stroke and chronic kidney disease. © 2012 Springer Science+Business Media, LLC.

引用

页码：281 / 290

页数：9

共 55 条

[1]

Build and Blood Pressure, 1, (1959)

[2]

Lew E.A., High blood pressure, other risk factors and longevity: the insurance viewpoint, Am J Med, 55, pp. 281-294, (1973)

[3]

Lewington S., Clarke R., Qizilbash N., Et al., Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, pp. 1903-1913, (2002)

[4]

Effects of different blood-pressure lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials, Lancet, 362, pp. 1527-1535, (2003)

[5]

Stewart I.M., Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension, Lancet, 313, pp. 861-865, (1979)

[6]

Cruickshank J.M., Thorp J.M., Zacharias F.J., Benefits and potential harm of lowering high blood pressure, Lancet, 329, pp. 581-584, (1987)

[7]

Farnett L., Mulrow C., Linn W.D., Et al., The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous?, Jama, 265, pp. 489-495, (1991)

[8]

Williams B., Hypertension and the J-curve, Jacc, 54, pp. 1835-1836, (2009)

[9]

Canty Jr. J.M., Coronary pressure-function and steady-state pressure-flow relations during autoregulation in the unanesthetized dog, Circ Res, 63, pp. 821-836, (1988)

[10]

Polese A., de Cesare N., Montorsi P., Et al., Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle, Circulation, 83, pp. 845-853, (1991)

← 1 2 3 4 5 6 →